The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study.
about
The relationship between Lp(a) and CVD outcomes: a systematic reviewC-reactive protein (CRP)-lowering agentsPrognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent ImplantationDiscordant association of C-reactive protein with clinical events and coronary luminal narrowing in postmenopausal women: data from the Women's Angiographic Vitamin and Estrogen (WAVE) study.Impact of Homocysteine Level on Long-term Cardiovascular Outcomes in Patients after Coronary Artery Stenting.Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary events.C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study.PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stentingHyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.The drug-based pipeline against restenosis.Inflammatory markers: linking unstable plaques to coronary event, an interventional perspective.Prognostic Value of Elevated Homocysteine Levels in Korean Patients with Coronary Artery Disease: A Propensity Score Matched Analysis.Atherogenesis: the role of inflammation and infection.Lipoprotein(a) for risk assessment in patients with established coronary artery disease.New strategies in the treatment of coronary bifurcations.Do statins have a role in reduction/prevention of post-PCI restenosis?Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients.Percutaneous coronary intervention-induced variations in systemic parameters of inflammation: relationship with the mode of stenting.Impact of high lipoprotein(a) levels on in-stent restenosis and long-term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug-eluting stents in Asian population.Association between hyperleptinemia and cardiovascular outcomes in patients with coronary artery disease
P2860
Q26749317-6DDDEF9C-CF43-4BA0-9445-624E80AE06BCQ28200344-B147EB8D-2172-461E-8712-BBCF375962D6Q28548500-0BE985F1-1207-471F-A3D5-51038AB555A5Q30645084-D7C3506A-A1F7-4162-94D9-8501E12CFE08Q33918747-F488A0A0-8BCB-4FE7-8362-37ECCBAB9871Q33962588-5EB168BE-4BDE-4A65-B331-2306FECBF2DEQ35582280-1D37A486-DF6C-4A7D-99F1-5097A3274D7BQ35771481-EBFF7018-F925-488A-B31B-E32BD532F30FQ35925719-343ACB0E-C018-43EC-B3E9-0688ADAAEC21Q35954252-5A660C73-109A-4475-9B8A-50F66EC8C8B9Q36066019-7143BD2B-5041-43A2-8894-9305B53FD8BBQ36251197-2794CB9B-6C14-4D6D-90AF-E2DEEB354800Q36723469-890B86A2-7A21-4192-AAD7-41BC8716C7CEQ36774193-59BB6580-855B-4034-B9D7-97ABC0F9A2E2Q37622149-5BDBBEB4-93A6-423C-96C3-02A44D972A4AQ37871912-7AF5D58B-71A5-43AF-8267-E05ADFBC6528Q37941867-C8F7DEE9-8C13-4BF2-BE5D-A15F48A0289AQ46911135-5BA9EA70-B5C1-4EB4-B631-FAB9E4F8E551Q51024156-DDFA9AA0-3124-4BCE-A16D-70BB0763639DQ53224566-FC6026AB-1224-48E2-8A94-C1F478E42AB4Q57489136-65E7B9F7-816D-411F-9778-9624FA3A4CB8
P2860
The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The impact of plasma levels of ...... fter Stent Implantation Study.
@en
The impact of plasma levels of ...... fter Stent Implantation Study.
@nl
type
label
The impact of plasma levels of ...... fter Stent Implantation Study.
@en
The impact of plasma levels of ...... fter Stent Implantation Study.
@nl
prefLabel
The impact of plasma levels of ...... fter Stent Implantation Study.
@en
The impact of plasma levels of ...... fter Stent Implantation Study.
@nl
P2093
P1476
The impact of plasma levels of ...... fter Stent Implantation Study.
@en
P2093
Alexander S Stefanidis
Christopher D Olympios
Constantine N Fakiolas
Evangelos G Pissimissis
Global Evaluation of New Events and Restenosis After Stent Implantation Study Group
Helen I Bilianou
John A Ambrose
Mary C DeVoe
Michael N Zairis
Olga A Papadaki
P304
P356
10.1016/S0735-1097(02)02267-2
P407
P577
2002-10-01T00:00:00Z